Research For better living


Apart from the fact that your customers expect your drugs to be absolutely safe, they also expect them to be effective. Our experts support your candidate drug development with an integrated preclinical pharmacokinetic program, including in vitro, in silico and in vivo ADME/DMPK services in various safety and disease models (PKPD).

Our knowledge and expertise stand out, enabling us to generate additional information about your drug during development and beyond. We contribute to the development of safe and effective drugs by providing integrated support for bioavailability and ADME-PK from drug discovery to preclinical and clinical development.